Chemomab Therapeutics Ltd盘中异动股价大跌6.12%报1.18美元

市场透视2025-05-14

北京时间2025年05月14日23时41分，Chemomab Therapeutics Ltd（CMMB.us）股票出现异动，股价大幅下挫6.12%。截至发稿，该股报1.18美元/股，成交量4.772万股，换手率0.25%，振幅6.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.01百万美元，每股收益-0.78美元，毛利-53251.55美元，市盈率-1.54倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535307447?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-14 23:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535307447","market":"us","top_or_hot":-1,"title":"Chemomab Therapeutics Ltd盘中异动 股价大跌6.12%报1.18美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月14日23时41分，Chemomab Therapeutics Ltd（CMMB.us）股票出现异动，股价大幅下挫6.12%。截至发稿，该股报1.18美元/股，成交量4.772万股，换手率0.25%，振幅6.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.01百万美元，每股收益-0.78美元，毛利-53251.55美元，市盈率-1.54倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234116aa2c8ec4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chemomab Therapeutics Ltd盘中异动 股价大跌6.12%报1.18美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChemomab Therapeutics Ltd盘中异动 股价大跌6.12%报1.18美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-14 23:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234116aa2c8ec4&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月14日23时41分，Chemomab Therapeutics Ltd（CMMB.us）股票出现异动，股价大幅下挫6.12%。截至发稿，该股报1.18美元/股，成交量4.772万股，换手率0.25%，振幅6.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.01百万美元，每股收益-0.78美元，毛利-53251.55美元，市盈率-1.54倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234116aa2c8ec4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CMMB","symbol_name":"Chemomab Therapeutics Ltd.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234116aa2c8ec4&s=b","article_id":"2535307447","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234116aa2c8ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535307447","pubTimestamp":1747237276,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月14日23时41分，Chemomab Therapeutics Ltd股票出现异动，股价大幅下挫6.12%。截至发稿，该股报1.18美元/股，成交量4.772万股，换手率0.25%，振幅6.69%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.32%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CMMB":"Chemomab Therapeutics Ltd.","BK4139":"生物科技","LENZ":"Therapeutics","BK4539":"次新股","BK4007":"制药"},"translate_title":"Chemomab Therapeutics Ltd shares fell 6.12% to $1.18 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"CMMB":0.9},"content_text":"北京时间2025年05月14日23时41分，Chemomab Therapeutics Ltd（CMMB.us）股票出现异动，股价大幅下挫6.12%。截至发稿，该股报1.18美元/股，成交量4.772万股，换手率0.25%，振幅6.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-14.01百万美元，每股收益-0.78美元，毛利-53251.55美元，市盈率-1.54倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.32%。其相关个股中，Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 (To Pur Com)、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3847.84%、3809.05%、1550.91%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Onconetix, Inc.，振幅分别为339.54%、201.95%、135.53%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司的候选药物CM-101是一种针对CCL24的单克隆抗体，已经证明可以通过新颖和独特的作用机制干预肝脏、皮肤和肺部纤维化的基础生物学过程。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535307447","isCrawlerRequest":true}

Chemomab Therapeutics Ltd盘中异动 股价大跌6.12%报1.18美元

精彩评论

Chemomab Therapeutics Ltd盘中异动股价大跌6.12%报1.18美元